Santwana Padhi

1.5k total citations · 1 hit paper
15 papers, 843 citations indexed

About

Santwana Padhi is a scholar working on Molecular Biology, Biomaterials and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Santwana Padhi has authored 15 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Biomaterials and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Santwana Padhi's work include Nanoparticle-Based Drug Delivery (6 papers), Cancer therapeutics and mechanisms (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Santwana Padhi is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Cancer therapeutics and mechanisms (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Santwana Padhi collaborates with scholars based in India, Malaysia and Saudi Arabia. Santwana Padhi's co-authors include Anindita Behera, Amit Kumar Nayak, Devina Verma, Tahir Khuroo, Sushama Talegaonkar, Amulya K. Panda, Zeenat Iqbal, Zeenat Iqbal, Hira Choudhury and Bapi Gorain and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Molecular Liquids and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Santwana Padhi

14 papers receiving 828 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type II diabetes mellitus: a review on recent drug based therapeutics

2020 430 citations Santwana Padhi, Amit Kumar Nayak et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Santwana Padhi India	10	305	207	156	131	114	15	843
Mahdi Hatamipour Iran	18	533 1.7×	126 0.6×	193 1.2×	115 0.9×	139 1.2×	37	1.6k
Ashwini Kumar India	15	262 0.9×	188 0.9×	114 0.7×	131 1.0×	53 0.5×	47	1.1k
Joana R. Campos Portugal	11	161 0.5×	84 0.4×	147 0.9×	175 1.3×	104 0.9×	19	691
Kshama Devi India	17	233 0.8×	133 0.6×	132 0.8×	303 2.3×	41 0.4×	34	895
Leander Corrie India	20	312 1.0×	87 0.4×	100 0.6×	207 1.6×	65 0.6×	42	992
Yanting Huang China	10	281 0.9×	81 0.4×	66 0.4×	145 1.1×	53 0.5×	32	896
Bikash Manandhar Australia	17	417 1.4×	195 0.9×	92 0.6×	29 0.2×	58 0.5×	35	1.0k
Florin Borcan Romania	17	340 1.1×	109 0.5×	78 0.5×	74 0.6×	51 0.4×	84	894
Zhengqi Dong China	17	319 1.0×	39 0.2×	159 1.0×	120 0.9×	89 0.8×	72	810

Countries citing papers authored by Santwana Padhi

Since Specialization

Citations

This map shows the geographic impact of Santwana Padhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santwana Padhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santwana Padhi more than expected).

Fields of papers citing papers by Santwana Padhi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Santwana Padhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santwana Padhi. The network helps show where Santwana Padhi may publish in the future.

Co-authorship network of co-authors of Santwana Padhi

This figure shows the co-authorship network connecting the top 25 collaborators of Santwana Padhi. A scholar is included among the top collaborators of Santwana Padhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Santwana Padhi. Santwana Padhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Behera, Anindita & Santwana Padhi. (2025). Targeted Nanotechnology.

Mirza, Mohd. Aamir, Santwana Padhi, Sradhanjali Mohapatra, et al.. (2024). Fisetin from Dietary Supplement to a Drug Candidate: An Assessment of Potential. Current Pharmaceutical Biotechnology. 26(8). 1143–1158. 2 indexed citations

Dey, Jyotirmayee, et al.. (2022). Nanotechnology and COVID-19 Convergence: Toward New Planetary Health Interventions Against the Pandemic. OMICS A Journal of Integrative Biology. 26(9). 473–488. 19 indexed citations

Das, S. R., et al.. (2022). Hospital-Based Prevalence, Electroencephalogram (EEG), and Neuroimaging Correlation in Seizures Among Children in Odisha, India. Cureus. 14(1). e21103–e21103. 2 indexed citations

Hassan, Nazia, et al.. (2021). Investigating natural antibiofilm components: a new therapeutic perspective against candidal vulvovaginitis. Medical Hypotheses. 148. 110515–110515. 6 indexed citations

Chatterjee, Rahul, Mrinmoy Ghosh, Santwana Padhi, et al.. (2021). Next-Generation Bioinformatics Approaches and Resources for Coronavirus Vaccine Discovery and Development—A Perspective Review. Vaccines. 9(8). 812–812. 17 indexed citations

Padhi, Santwana, et al.. (2021). Nanophytochemicals for the treatment of type II diabetes mellitus: a review. Environmental Chemistry Letters. 19(6). 4349–4373. 23 indexed citations

Patnaik, Soma, Bapi Gorain, Santwana Padhi, et al.. (2021). Recent update of toxicity aspects of nanoparticulate systems for drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 161. 100–119. 61 indexed citations

Mohapatra, Sradhanjali, Zeenat Iqbal, Sayeed Ahmad, et al.. (2020). Menopausal Remediation and Quality of Life (QoL) Improvement: Insights and Perspectives. Endocrine Metabolic & Immune Disorders - Drug Targets. 20(10). 1624–1636. 9 indexed citations

10.

Padhi, Santwana, Amit Kumar Nayak, & Anindita Behera. (2020). Type II diabetes mellitus: a review on recent drug based therapeutics. Biomedicine & Pharmacotherapy. 131. 110708–110708. 430 indexed citations breakdown →

11.

Behera, Anindita & Santwana Padhi. (2020). Passive and active targeting strategies for the delivery of the camptothecin anticancer drug: a review. Environmental Chemistry Letters. 18(5). 1557–1567. 94 indexed citations

12.

Padhi, Santwana, Rohit Kapoor, Devina Verma, Amulya K. Panda, & Zeenat Iqbal. (2018). Formulation and optimization of topotecan nanoparticles: In vitro characterization, cytotoxicity, cellular uptake and pharmacokinetic outcomes. Journal of Photochemistry and Photobiology B Biology. 183. 222–232. 29 indexed citations

13.

Verma, Devina, et al.. (2017). Design expert assisted nanoformulation design for co-delivery of topotecan and thymoquinone: Optimization, in vitro characterization and stability assessment. Journal of Molecular Liquids. 242. 382–394. 45 indexed citations

14.

Padhi, Santwana, Mohd. Aamir Mirza, Devina Verma, et al.. (2015). Revisiting the nanoformulation design approach for effective delivery of topotecan in its stable form: an appraisal of its in vitro Behavior and tumor amelioration potential. Drug Delivery. 23(8). 2827–2837. 31 indexed citations

15.

Khuroo, Tahir, Devina Verma, Sushama Talegaonkar, et al.. (2014). Topotecan–tamoxifen duple PLGA polymeric nanoparticles: Investigation of in vitro, in vivo and cellular uptake potential. International Journal of Pharmaceutics. 473(1-2). 384–394. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact